ArticleJournal of viral hepatitis2022

Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real-world cohorts.

Jordan J Feld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.